Harvard Bioscience, Inc. (HBIO)
8.46
-0.10
(-1.17%)
USD |
NASDAQ |
Oct 07, 16:00
8.46
0.00 (0.00%)
After-Hours: 16:43
Harvard Bioscience Max Drawdown (5Y) : 96.64% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.64% |
| August 31, 2026 | 96.64% |
| July 31, 2026 | 96.64% |
| June 30, 2026 | 96.64% |
| May 31, 2026 | 96.64% |
| April 30, 2026 | 96.64% |
| March 31, 2026 | 96.64% |
| February 28, 2026 | 96.64% |
| January 31, 2026 | 96.64% |
| December 31, 2025 | 96.64% |
| November 30, 2025 | 96.64% |
| October 31, 2025 | 96.64% |
| September 30, 2025 | 96.64% |
| August 31, 2025 | 96.64% |
| July 31, 2025 | 96.64% |
| June 30, 2025 | 96.64% |
| May 31, 2025 | 96.64% |
| April 30, 2025 | 95.79% |
| March 31, 2025 | 93.32% |
| February 28, 2025 | 90.04% |
| January 31, 2025 | 79.81% |
| December 31, 2024 | 78.81% |
| November 30, 2024 | 78.81% |
| October 31, 2024 | 78.81% |
| September 30, 2024 | 78.81% |
| Date | Value |
|---|---|
| August 31, 2024 | 78.81% |
| July 31, 2024 | 78.81% |
| June 30, 2024 | 78.81% |
| May 31, 2024 | 78.81% |
| April 30, 2024 | 78.81% |
| March 31, 2024 | 78.81% |
| February 29, 2024 | 78.81% |
| January 31, 2024 | 78.81% |
| December 31, 2023 | 78.81% |
| November 30, 2023 | 78.81% |
| October 31, 2023 | 78.81% |
| September 30, 2023 | 78.81% |
| August 31, 2023 | 78.81% |
| July 31, 2023 | 78.81% |
| June 30, 2023 | 78.81% |
| May 31, 2023 | 78.81% |
| April 30, 2023 | 78.81% |
| March 31, 2023 | 78.81% |
| February 28, 2023 | 78.81% |
| January 31, 2023 | 78.81% |
| December 31, 2022 | 78.81% |
| November 30, 2022 | 78.81% |
| October 31, 2022 | 78.81% |
| September 30, 2022 | 78.81% |
| August 31, 2022 | 78.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agilent Technologies, Inc. | 43.19% |
| Bio-Rad Laboratories, Inc. | 73.77% |
| Bruker Corp. | 68.72% |
| Danaher Corp. | 43.81% |
| Illumina, Inc. | 86.25% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -54.13 |
| Beta (5Y) | 1.505 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 73.06% |
| Historical Sharpe Ratio (5Y) | -0.5348 |
| Historical Sortino (5Y) | -1.004 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.19% |